USFDA removes Jubilant Generics' Olanzapine, Spironolactone and Valsartan from the excepted products list
Post this currently only Risperidone orally disintegrating tablets are allowed for import into the US from the Roorkee facility.
Post this currently only Risperidone orally disintegrating tablets are allowed for import into the US from the Roorkee facility.
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
This agreement is in addition to the $92 million filling line expansion announced in November 2021
Fitch estimates JPL's EBITDA to drop significantly in FY23 due to lower volume and narrowing of the margin to 11% (FY22 estimate: 14%).
The company will engage with the agency to resolve the import alert at the earliest and ensure cGMP compliance.
Entered into a manufacturing partnership with Ocugen, Inc. for manufacturing of COVID-19 vaccine COVAXIN for the US and Canadian markets
This investment is being made to set up a high speed 400 vials a minute injectable fill line with isolator technology
The rating withdrawal is based on the company’s request and in line with CRISIL Rating’s policy on withdrawal of ratings.
Jubilant successfully challenged Bracco's patent infringement claims in an Inter Parties Review (IPR) proceeding before the U.S. Patent Office
The company posted net profit of Rs.203.38 crores for the period ended December 31, 2019.
Subscribe To Our Newsletter & Stay Updated